About Eisai China


Eisai’s affiliates in China are wholly-owned by Eisai Co., Ltd. (Eisai), a Japanese multinational pharmaceutical company with strong R&D capabilities, as global headquarter in Tokyo and headquarter of China in Shanghai.

Eisai has grown smoothly since entering the Chinese market in the early 1990s and the total registered capital in China is US$108.54 million. The member companies include Eisai China Holdings Ltd., Eisai China Inc., Eisai (Liaoning) Pharmaceutical Co., Ltd., Eisai (Suzhou) Trading Co., Ltd., Unlimit Health Limited (joint-venture) and etc., and promotes tens of pharmaceutical brands and other products in China, specializing in neurology, oncology and gastrointestinal areas, and expands to the generics and other business.

In 2018, the new factory officially opened, with a size of 23,364m2 located at Xingpu Road in Suzhou Industrial Park, and the production capacity has been rapidly increased as formulation of approximately 3 billion tablets / packaging for approximately 5 billion tablets per year. As one of the Eisai’s main factories, in the future, the products produced by the Suzhou factory will not only meet the needs of the Chinese market, but will also be supplied to 23 countries and regions in East Asia, Southeast Asia, the Middle East, Central and South America and Europe.

In pursuit of its human health care philosophy, Eisai’s affiliates in China strive to maintain the highest GMP standard in manufacturing products and strictly adhere to the highest level of ethics and compliance, and provide high-quality, eco-friendly, safe and satisfactory products and services to patients and their families.

At the same time, it has actively undertaken corporate social responsibility. In 2020, it has donated more than 15 million yuan in cash and medical supplies to fight the COVID 19. Since 2000, 2386 students have been rewarded and funded over 10 medical colleges and universities with a total subsidy exceeding 9 million yuan. Since 2013, 250,000 high-risk Alzheimer’s patients has been benefited from the “Remember I Love You-Yellow Bracelet” Project with the donation of more than 5 million yuan to the China Population Welfare Foundation. From 2014 to 2019, the medical products with a total amount of nearly 3 million yuan have been donated through “Health to Countryside” Project. So far, in cooperation with the China Primary Health Care Foundation, more than 2 billion yuan of medicines have been provided free of charge to cancer patients and their families, solving the patient’s family burden, greatly improving the accessibility and affordability of innovative drugs for patients. And, for several consecutive years, it has won honorary titles such as “Shanghai Civilization Unit”, “Top Employer China “, ” Greater Suzhou Best Employer”, “China’s Top 100 Pharmaceutical Industry”, “Award for Promoting Medical Public Welfare and Practicing Corporate Mission” and other honorary titles.